Skip to main content
Market intelligence
FTHSector not reported

Faeth Therapeutics, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $862,636 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$862,636
Corporate buyers
2
Latest transaction
Jun 26, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 26, 2026Brian C StephensonChief Financial OfficerOpen Market Purchase15,641$25.65$401,268
Jun 23, 2026Brian C StephensonChief Financial OfficerOpen Market Purchase17,413$23.31$405,921
Jun 22, 2026Anand Kiran ParikhPresident and CEOOpen Market Purchase2,806$19.76$55,447